Following a gift from Brown trustee Giammaria Giuliani P’28 and Sabrina Giuliani P’28, Brown’s RNA center will be named the ...
Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines ...
14hon MSNOpinion
Pfizer is said to divest remaining stake in BioNTech
BioNTech (BNTX) stock slips as Pfizer (PFE) plans to sell its remaining stake in the COVID-19 vaccine developer in a ...
9hon MSN
Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new
There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
TipRanks on MSN
Moderna Approves Stock Option Exchange Program
The first was a one-time stock option exchange program for non-Executive Committee employees, which received significant support from stockholders. The second proposal allowed for the adjournment of ...
Key opportunities in the RNA targeting small molecules therapeutics market include growth in RNA splicing modifications, neurodegenerative diseases, drug discovery, and pharma-biotech sectors.
Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after expressing the belief that messenger RNA Covid vaccines should be removed from ...
9don MSN
Molecular dynamics simulations use atomistic force field to capture RNA folding with high accuracy
Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...
Investor's Business Daily on MSN
Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing
Korro BioKRRO stock plummeted Thursday after its RNA-editing drug failed to pass muster in patients with a rare lung and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results